Dementia
Dementia
Advertisement
Leah LawrenceDementia | July 18, 2025
Ambroxol was safe in Parkinson disease dementia but showed no cognitive benefit, study finds.
Leah LawrenceDementia | July 15, 2025
Ambroxol was safe in Parkinson’s dementia but showed no clear cognitive benefit.
Leslie FeldmanDementia | July 7, 2025
Excess brain iron in Down syndrome linked to oxidative damage and early-onset Alzheimer’s, new study finds.
Rob Drolet, PhDNeurology | June 16, 2025
α-synuclein PET tracers may transform Parkinson’s diagnosis, tracking, and trials, says Merck’s Robert Drolet, PhD.
Jordana JampelDementia | May 16, 2025
The new blood test is less invasive and more accessible to patients.
Jordana JampelMelanoma | April 28, 2025
Parkinson's disease and melanoma are believed to be linked due to DNA double-strand break repair thus cell proliferation.
Jordana JampelDementia | April 25, 2025
The primary safety endpoint of minimal SAEs was met as well as the secondary endpoint of increased fluorodopa in the putamen.
Anne Marie Morse, DOSleep Disorders | February 19, 2025
Dr. Anne Marie Morse discusses the troubling connection between sleep disorders and dementia.
Jordana JampelStroke | February 6, 2025
The caps on the end of chromosomes are called telomeres.
Rob DillardDementia | January 8, 2025
A new model called the Florey Dementia Index (FDI) can accurately predict the age at onset of MCI and AD.
Jordana JampelDementia | December 18, 2024
The research group will design a vaccine that won't promote inflammation.
Jordana JampelDementia | December 2, 2024
The phase 2 randomized trial included patients with amyloid-confirmed mild cognitive impairment or early Alzheimer disease.
Rob DillardDementia | December 16, 2024
Researchers assessed the molecular underpinnings that may increase the risk of Alzheimer’s disease following TBI.
Rob DillardDementia | September 16, 2024
Researchers have developed a novel therapy that selectively removes aggregated tau proteins, which are associated with AD.
Dr. Gus AlvaDementia | August 20, 2024
Dr. Alva discusses a study that evaluated the safety of pimavanserin in frail elderly patients with NDD.
Rebecca AraujoBreast Cancer News | July 17, 2024
Hormone therapy was associated with a 19% lower relative risk in Black women aged 65 to 74 years.
Rebecca AraujoDementia | June 21, 2024
A 5-minute assessment was found to improve the diagnosis of mild cognitive impairment and dementia.
Rob DillardDementia | June 18, 2024
People who inherit a history of Alzheimer disease from their mother's side have a higher risk of developing AD.
Rob DillardSleep Disorders | May 13, 2024
Midpoint of sleep is associated with multiple measures of sleep quality and could be a biomarker for AD risk.
Rebecca AraujoMental Health | May 9, 2024
Xanomeline-trospium chloride is effective and well tolerated in patients with schizophrenia experiencing acute psychosis.
Advertisement